Expertise Stay on-time and on-budget >

ExpertiseStay on-time and on-budget;
rely on specialized plasmid expertise more >

Technology 9.5 times higher purity >

Technology9.5 times higher purity and 99% lot-to-lot consistency with patented technology more >

Partnership Focused on clinical success >

PartnershipFocused on clinical success;
we share your vision and your commitment more >

GeoVax

Seeking a preventive cure for AIDS

GeoVax has successfully entered Phase II trials for its
AIDS vaccines that work against multiple HIV-1 proteins,
to protect against the development of AIDS in HIV-infected
humans. VGXI provides DNA Plasmids for these clinical trials.

Learn more

Coridon

In pursuit of the world's first Herpes prophalaxis

Following his research that led to a successful HPV vaccine,
Prof. Ian Frazer is leading Coridon into Phase I trials for a
combined prophylactic and therapeutic HSV-2 vaccine. VGXI
successfully scaled a fermentation process to stay on schedule.

Learn more

Inovio

Advancing the science of DNA vaccines

Pioneering in DNA vaccines with innovative drug delivery
that increases cell membrane permeability for greater
therapeutic absorption by as much as 1000x. Inovio relies
on VGXI for highly concentrated DNA Plasmids.

Learn more